[1] Jackson SP, Bartek J. The DNA–damage response in human biology and disease. Nature, 2009, 461(7267): 1071–1078. <\p>
[2] Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell, 2010, 40(2): 179– 204. <\p>
[3] Jackson SP. The DNA–damage response: new molecular insights and new approaches to cancer therapy. Biochem Soc Trans, 2009, 37(Pt 3): 483–494. <\p>
[4] Huen MS, Chen J. Assembly of checkpoint and repair machineries at DNA damage sites. Trends Biochem Sci, 2010, 35(2): 101–108. <\p>
[5] Polo SE, Jackson SP. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev, 2011, 25(5): 409–433. <\p>
[6] Cheadle C, Fan J, Cho–Chung YS, Werner T, Ray J, Do L, Gorospe M, Becker KG. Stability regulation of mRNA and the control of gene expression. Ann N Y Acad Sci, 2005, 1058: 196–204. <\p>
[7] Boucas J, Riabinska A, Jokic M, Herter–Sprie GS, Chen S, Höpker K, Reinhardt HC. Posttranscriptional regulation of gene expression–adding another layer of complexity to the DNA damage response. Front Genet, 2012, 3: 159. <\p>
[8] Bhaskaran M, Mohan M. MicroRNAs: history, biogenesis, and their evolving role in animal development and disease. Vet Pathol, 2013, <\p>
[Epub ahead of print]. <\p>
[9] Wouters MD, van Gent DC, Hoeijmakers JH, Pothof J. MicroRNAs, the DNA damage response and cancer. Mutat Res, 2011, 717(1–2): 54–66. <\p>
[10] Stracker TH, Roig I, Knobel PA, Marjanovi? M. The ATM signaling network in development and disease. Front Genet, 2013, 4: 37. <\p>
[11] Lal A, Pan YF, Navarro F, Dykxhoorn DM, Moreau L, Meire E, Bentwich Z, Lieberman J, Chowdhury D. miR–24–mediated downregulation of H2AX suppresses DNA repair in terminally differentiated blood cells. Nat Struct Mol Biol, 2009, 16(5): 492–498. <\p>
[12] Wang YM, Huang JW, Li M, Cavenee WK, Mitchell PS, Zhou XF, Tewari M, Furnari FB, Taniguchi T. MicroRNA– 138 modulates DNA damage response by repressing histone H2AX expression. Mol Cancer Res, 2011, 9(8): 1100–1111. <\p>
[13] Roos WP, Kaina B. DNA damage–induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett, 2013, 332(2): 237–248. <\p>
[14] Hu HL, Du LT, Nagabayashi G, Seeger RC, Gatti RA. ATM is down–regulated by N–Myc–regulated microRNA– 421. Proc Natl Acad Sci USA, 2010, 107(4): 1506–1511. <\p>
[15] Ng WL, Yan D, Zhang XM, Mo YY, Wang Y. Over– expression of miR–100 is responsible for the low–expression of ATM in the human glioma cell line: M059J. DNA Repair, 2010, 9(11): 1170–1175. <\p>
[16] Yan D, Ng WL, Zhang XM, Wang P, Zhang ZB, Mo YY, Mao H, Hao CH, Olson JJ, Curran WJ, Wang Y. Targeting DNA–PKcs and ATM with miR–101 sensitizes tumors to radiation. PloS ONE, 2010, 5(7): e11397. <\p>
[17] Song LB, Lin CY, Wu ZQ, Gong H, Zeng Y, Wu JH, Li MF, Li J. miR–18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase. PloS ONE, 2011, 6(9): e25454. <\p>
[18] Bisso A, Faleschini M, Zampa F, Capaci V, De Santa J, Santarpia L, Piazza S, Cappelletti V, Daidone M, Agami R, Del Sal G. Oncogenic miR–181a/b affect the DNA damage response in aggressive breast cancer. Cell Cycle, 2013, 12(11): 1679–1687. <\p>
[19] Wang J, He J, Su F, Ding N, Hu W, Yao B, Wang W, Zhou G. Repression of ATR pathway by miR–185 enhances radiation–induced apoptosis and proliferation inhibition. Cell Death Disease, 2013, 4(6): e699. <\p>
[20] Chang L, Hu WT, Ye CY, Yao B, Song L, Wu X, Ding N, Wang JF, Zhou G |